Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 10.80
-0.20 (-1.82%)
Sep 11, 2026, 2:32 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 47.86 million as of September 11, 2026. Its market cap has increased by 121.39% in one year.
Market Cap
47.86M
Enterprise Value
45.10M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.80
ChartMarket Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 47.86M, a decrease of -52.60%. That is a compound annual growth rate of -12.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 47.86M | 72.54% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.37B |
| GSK plc | 71.14B |
| Haleon | 29.62B |
| Smith & Nephew | 8.63B |
| Ondine Biomedical | 58.45M |
| Creo Medical Group | 56.14M |
| MedPal AI | 51.29M |
| Shield Therapeutics | 49.86M |